Digital Daily News… Read the rest “Uveitis Treatment Market is likely to expand at a stable CAGR of 6.5% During 2016-2024”
Digital Daily News… Read the rest “Uveitis Treatment Market is likely to expand at a stable CAGR of 6.5% During 2016-2024”
Crain’s Detroit Business… Read the rest “BlueWater Angels among state’s most enviable investors”
Waco Tribune-Herald… Read the rest “Allergan prepares to expand Waco facility after delays”
During its 20th Year, Angel Network also Launched Angel Syndication Network to Share Deals with over 20 Other Angel Groups
IRVINE, Calif. – April 25, 2017 – Tech Coast Angels (TCA) invested $14.1 million in a total of 55 companies in a diverse mix of industries in 2016.… Read the rest “Tech Coast Angels Invested $14.1 Million into 55 Companies and Completed Six Exits in 2016”
Crain’s Detroit Business… Read the rest “Retrosense Therapeutics: Looking beyond Traverse City’s tourism: Northern Michigan angel fund aims to broaden economic base, create year-round jobs”
click here… Read the rest “Retrosense Therapeutics: Life sciences sector is heartbeat of Michigan innovation”
click here… Read the rest “Retrosense Therapeutics: Tech innovators honored at Michigan Venture Capital Association awards dinner”
click here… Read the rest “Retrosense Therapeutics: What Allergan Is Buying and Shedding to Gain a Better Position”
click here… Read the rest “RetroSense to be honored at TechTown awards program for $60 million sale”
click here… Read the rest “The RetroSense Story: A Life Science Journey to Success”
click here… Read the rest “Retrosense Therapeutics: WSU research leads to algae treatment for blindness”
click here… Read the rest “With small RetroSense deal, Allergan hoping for big win”
click here… Read the rest “Allergan seizes visionary Optogenetic Therapy from US Startup Retrosense Therapeutics”
click here… Read the rest “Allergan buys gene therapy company, RetroSense Therapeutics”
click here… Read the rest “Allergan acquires RetroSense Therapeutics”
click here… Read the rest “Allergan Acquires RetroSense Therapeutics”
click here… Read the rest “Allergan Acquires Gene Therapy Company RetroSense Therapeutics Adding First-In-Class Technology to Company’s Innovative Eye Care Pipeline”
click here… Read the rest “BRIEF-Allergan acquires gene therapy company Retrosense Therapeutics”
click here… Read the rest “Allergan (AGN) Acquires RetroSense Therapeutics”
click here… Read the rest “Allergan Acquires Gene Therapy Company RetroSense Therapeutics Adding First-In-Class Technology to Company’s Innovative Eye Care Pipeline”
click here… Read the rest “Allergan snaps up gene therapy startup Retrosense Therapeutics to restore vision in rare disease patients”
click here… Read the rest “RetroSense Therapeutics Secures Exclusive Worldwide Rights to ReaChR Optogene from the University of California San Diego”
click here… Read the rest “RetroSense Therapeutics Completes Low Dose Cohort in Clinical Trial of Novel Gene Therapy Application of Optogenetics”
click here… Read the rest “RetroSense Therapeutics Completes Low Dose Cohort in Clinical Trial of Novel Gene Therapy Application of Optogenetics”
click here… Read the rest “RetroSense Therapeutics Completes Low Dose Cohort in Clinical Trial of Novel Gene Therapy Application of Optogenetics”
click here… Read the rest “RetroSense Therapeutics has been named one of the nation’s 50 smartest companies by the MIT Technology Review”
click here… Read the rest “RetroSense Therapeutics Tech magazine ranks Wayne State spinoff as 37th smartest company in world”
click here… Read the rest “RetroSense Therapeutics Selected as one of MIT Technology Review’s 50 Smartest Companies of 2016”
click here… Read the rest “RetroSense Therapeutics Selected as one of MIT Technology Review’s 50 Smartest Companies of 2016”
click here… Read the rest “RetroSense Therapeutics Selected as a Red Herring Top 100 North America Winner”
click here… Read the rest “Light-controlled genes and neurons poised for clinical trials”
click here… Read the rest “RetroSense Therapeutics to Highlight Contributions to Gene Therapy Research in Upcoming Conferences”
Southern California Angel Network Surpasses Previous Records for Both Investments and Activity
IRVINE, Calif. January 29, 2015 Tech Coast Angels (TCA) invested a total of $16,373,337 in 61 total deals in Calendar Year 2014. The angel network announced that 2014 was the most active year since the networks inception in 1997 for number of deals funded, and capital raised was also the largest ever.… Read the rest “Tech Coast Angels Invested Best Ever $16.37 Million in 2014”